Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease Trial Phase 2 Terminated April 15, 2019
Contribution of Virtual Reality and Modelling in Falling Risk Assessment in Elderly and Parkinson's Disease Patients Trial N/A Unknown April 15, 2019
Relationship Between Symptoms, Retinal Morphology, and the Nigrostriatal Dopamine System in Parkinson's Disease Trial N/A Completed April 11, 2019
Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations Trial Phase 2 Terminated April 11, 2019
Precision Medical Diagnosis for Parkinson's Disease - The Quantitative Analysis System for PET/MRI Images in Patients Trial N/A Unknown April 9, 2019
The Effect of Dual Tasking on Physical and Cognitive Functions in Patients With Parkinson Disease Trial N/A Completed April 4, 2019
The Effect of Parkinson Kinetigraph Recordings on the Management and Outcome in Parkinson's Disease Trial N/A Completed April 3, 2019
neuroQWERTY: a Transparent Patient-centered Outcome Method to Quantify Parkinsonian Motor Signs for Drug Trials Trial N/A Completed April 3, 2019
Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological Conditions Trial Phase 1 Terminated April 2, 2019
Study of Brain Imaging With Nuclear Technology in Individuals With Parkinsonian Syndrome Trial Phase 2 Completed April 2, 2019
The Study of the Impact of Disclosing Imaging Study Information to Trial Participants Trial N/A Completed April 2, 2019
Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients Trial Phase 3 Terminated April 2, 2019
A Study of the Sense of Smell in Relatives of Parkinson's Disease Patients Trial N/A Completed April 2, 2019
Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With PD or AD and in Healthy Subjects Trial Phase 1 Terminated April 2, 2019
Effects of Rhythmic Auditory Cueing on Stepping in Place in Patients With Parkinson's Disease Trial N/A Completed April 1, 2019
Clinical Study of KDT-3594 in Healthy Adult Males and Patients With Parkinson's Disease Trial Phase 1 Completed March 31, 2019
Effect of Short-term Motilitone Therapy on Health-related Quality of Life in PD Patients With Gastrointestinal Symptoms Trial Phase 4 Completed March 27, 2019
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder Trial Phase 2 Terminated March 26, 2019
Feasibility of the AHA Exergame System in Parkinson's Disease Patients Trial N/A Completed March 25, 2019